Journal for ImmunoTherapy of Cancer (Nov 2023)
1147-A TNRX-257, a multifunctional LAG3 antagonist and conditional IL2Rϒ/ß partial agonist, is a novel immune stimulant with high dose tolerability in non-human primates
Abstract
No abstracts available.